{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:59:09Z","timestamp":1780513149562,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,10,22]],"date-time":"2011-10-22T00:00:00Z","timestamp":1319241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00105-011-2144-7","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T16:22:36Z","timestamp":1319127756000},"page":"820-827","source":"Crossref","is-referenced-by-count":9,"title":["Rosazea","Rosacea"],"prefix":"10.1007","volume":"62","author":[{"given":"A.","family":"Thielitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Gollnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,22]]},"reference":[{"key":"2144_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9440(10)62973-2","volume":"167","author":"Adams","year":"2005","unstructured":"Adams J, Kiss E, Arroyo AB et al (2005) 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol 167:285\u2013298","journal-title":"Am J Pathol"},{"key":"2144_CR2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(94)90377-8","volume":"344","author":"Becherel","year":"1994","unstructured":"Becherel PA, Mossalayi MD, LeGoff L et al (1994) Mechanism of anti-inflammatory action of retinoids on keratinocytes. Lancet 344:1570\u20131571","journal-title":"Lancet"},{"key":"2144_CR3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s000110050216","volume":"46","author":"Bohne","year":"1997","unstructured":"Bohne M, Struy H, Gerber A, Gollnick H (1997) Effects of retinoids on the generation of neutrophil-derived reactive oxygen species studied by EPR spin trapping techniques. Inflamm Res 46:423\u2013424","journal-title":"Inflamm Res"},{"key":"2144_CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/00015555-0888","volume":"90","author":"Bostanci","year":"2010","unstructured":"Bostanci O, Borelli C, Schaller M (2010) Treatment of extrafacial rosacea with low-dose isotretinoin. Acta Derm Venereol 90:409\u2013410","journal-title":"Acta Derm Venereol"},{"key":"2144_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","volume":"25","author":"Elewski","year":"2011","unstructured":"Elewski BE, Draelos Z, Dreno B et al (2011) Rosacea \u2013 global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol 25:188\u2013200","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2144_CR6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archderm.134.7.884","volume":"134","author":"Erdogan","year":"1998","unstructured":"Erdogan FG, Yurtsever P, Aksoy D, Eskioglu F (1998) Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 134:884\u2013885","journal-title":"Arch Dermatol"},{"key":"2144_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.130.3.319","volume":"130","author":"Ertl","year":"1994","unstructured":"Ertl GA, Levine N, Kligman AM (1994) A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 130:319\u2013324","journal-title":"Arch Dermatol"},{"key":"2144_CR8","first-page":"127","volume":"16","author":"Fathy","year":"2009","unstructured":"Fathy A, Mohamed RW, Ismael NA, El-Akhras MA (2009) Expression of toll-like receptor 2 on peripheral blood monocytes of patients with inflammatory and noninflammatory acne vulgaris. Egypt J Immunol 16:127\u2013134","journal-title":"Egypt J Immunol"},{"key":"2144_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1610-0387.2009.07238.x","volume":"8","author":"Ganceviciene","year":"2010","unstructured":"Ganceviciene R, Zouboulis CC (2010) Isotretinoin: state of the art treatment for acne vulgaris. J Dtsch Dermatol Ges 8(Suppl 1):47\u201359","journal-title":"J Dtsch Dermatol Ges"},{"key":"2144_CR10","first-page":"996","volume":"7","author":"Gauwerky","year":"2009","unstructured":"Gauwerky K, Klovekorn W, Korting HC et al (2009) Rosazea. J Dtsch Dermatol Ges 7:996\u20131003","journal-title":"J Dtsch Dermatol Ges"},{"key":"2144_CR11","first-page":"505","volume":"8","author":"Gollnick","year":"2010","unstructured":"Gollnick H, Blume-Peytavi U, Szabo EL et al (2010) Systemic isotretinoin in the treatment of rosacea \u2013 doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 8:505\u2013515","journal-title":"J Dtsch Dermatol Ges"},{"key":"2144_CR12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-4362.1986.tb04533.x","volume":"25","author":"Hoting","year":"1986","unstructured":"Hoting E, Paul E, Plewig G (1986) Treatment of rosacea with isotretinoin. Int J Dermatol 25:660\u2013663","journal-title":"Int J Dermatol"},{"key":"2144_CR13","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.4049\/jimmunol.174.5.2467","volume":"174","author":"Liu","year":"2005","unstructured":"Liu PT, Krutzik SR, Kim J, Modlin RL (2005) Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol 174:2467\u20132470","journal-title":"J Immunol"},{"key":"2144_CR14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2230.1984.tb00842.x","volume":"9","author":"Marsden","year":"1984","unstructured":"Marsden JR, Shuster S, Neugebauer M (1984) Response of rosacea to isotretinoin. Clin Exp Dermatol 9:484\u2013488","journal-title":"Clin Exp Dermatol"},{"key":"2144_CR15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/jid.2009.435","volume":"130","author":"Morizane","year":"2010","unstructured":"Morizane S, Yamasaki K, Kabigting FD, Gallo RL (2010) Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J Invest Dermatol 130:1297\u20131306","journal-title":"J Invest Dermatol"},{"key":"2144_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4161\/derm.1.3.8258","volume":"1","author":"Nelson","year":"2009","unstructured":"Nelson AM, Zhao W, Gilliland KL et al (2009) Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol 1:177\u2013187","journal-title":"Dermatoendocrinol"},{"key":"2144_CR17","first-page":"575","volume":"32","author":"Nikolowski","year":"1981","unstructured":"Nikolowski J, Plewig G (1981) Orale Behandlung der Rosazea mit 13-cis-Retins\u00e4ure. Hautarzt 32:575\u2013584","journal-title":"Hautarzt"},{"key":"2144_CR18","first-page":"173","volume":"168","author":"Nikolowski","year":"1982","unstructured":"Nikolowski J, Plewig G, Hofmann C (1982) In-vivo-Tests zum Nachweis der antiinflammatorischen Wirkung der 13-cis-Retins\u00e4ure. Dermatol Monatsschr 168:173\u2013181","journal-title":"Dermatol Monatsschr"},{"key":"2144_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1523-1747.ep12580370","volume":"89","author":"Norris","year":"1987","unstructured":"Norris DA, Osborn R, Robinson W, Tonnesen MG (1987) Isotretinoin produces significant inhibition of monocyte and neutrophil chemotaxis in vivo in patients with cystic acne. J Invest Dermatol 89:38\u201343","journal-title":"J Invest Dermatol"},{"key":"2144_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2133.1983.tb11613.x","volume":"109","author":"Orfanos","year":"1983","unstructured":"Orfanos CE, Bauer R (1983) Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br J Dermatol 109:55\u201360","journal-title":"Br J Dermatol"},{"key":"2144_CR21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.0022-202X.2005.23848.x","volume":"125","author":"Papakonstantinou","year":"2005","unstructured":"Papakonstantinou E, Aletras AJ, Glass E et al (2005) Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol 125:673\u2013684","journal-title":"J Invest Dermatol"},{"key":"2144_CR22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0190-9622(82)70067-2","volume":"6","author":"Plewig","year":"1982","unstructured":"Plewig G, Nikolowski J, Wolff HH (1982) Action of isotretinoin in acne rosacea and gram-negative folliculitis. J Am Acad Dermatol 6:766\u2013785","journal-title":"J Am Acad Dermatol"},{"key":"2144_CR23","unstructured":"Plewig G (2005) Akne und Rosazea. In: Braun-Falco O, Plewig G, Wolff H et al (Hrsg) Dermatologie und Venerologie. 5. Aufl. Springer, Heidelberg"},{"key":"2144_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/archdermatol.2010.413","volume":"147","author":"Scharschmidt","year":"2011","unstructured":"Scharschmidt TC, Yost JM, Truong SV et al (2011) Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment. Arch Dermatol 147:123\u2013126","journal-title":"Arch Dermatol"},{"key":"2144_CR25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2340\/00015555641521","volume":"64","author":"Schmidt","year":"1984","unstructured":"Schmidt JB, Gebhart W, Raff M, Spona J (1984) 13-cis-Retinoic acid in rosacea. Clinical and laboratory findings. Acta Derm Venereol 64:15\u201321","journal-title":"Acta Derm Venereol"},{"key":"2144_CR26","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00105-009-1825-y","volume":"60","author":"Sobottka","year":"2009","unstructured":"Sobottka A, Lehmann P (2009) Rosazea 2009: Neue Erkenntnisse zur Pathophysiologie, klinische Manifestationsformen und Therapiestrategien. Hautarzt 60:999\u20131009","journal-title":"Hautarzt"},{"key":"2144_CR27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1747.1998.00393.x","volume":"111","author":"Weninger","year":"1998","unstructured":"Weninger W, Rendl M, Mildner M, Tschachler E (1998) Retinoids downregulate vascular endothelial growth factor\/vascular permeability factor production by normal human keratinocytes. J Invest Dermatol 111:907\u2013911","journal-title":"J Invest Dermatol"},{"key":"2144_CR28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","volume":"13","author":"Yamasaki","year":"2007","unstructured":"Yamasaki K, Di NA, Bardan A et al (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13:975\u2013980","journal-title":"Nat Med"},{"key":"2144_CR29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","volume":"131","author":"Yamasaki","year":"2011","unstructured":"Yamasaki K, Kanada K, Macleod DT et al (2011) TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol 131:688\u2013697","journal-title":"J Invest Dermatol"},{"key":"2144_CR30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00412920","volume":"278","author":"Yoshioka","year":"1986","unstructured":"Yoshioka A, Miyachi Y, Imamura S, Niwa Y (1986) Anti-oxidant effects of retinoids on inflammatory skin diseases. Arch Dermatol Res 278:177\u2013183","journal-title":"Arch Dermatol Res"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-011-2144-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-011-2144-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-011-2144-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T23:08:08Z","timestamp":1713049688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-011-2144-7"}},"subtitle":["Systemische Therapie mit Retinoiden","Systemic therapy with retinoids"],"short-title":[],"issued":{"date-parts":[[2011,10,22]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["2144"],"URL":"https:\/\/doi.org\/10.1007\/s00105-011-2144-7","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,22]]}}}